Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares | The Motley Fool
This biotech innovator in rare disease therapies reported significant insider selling amid a year of robust stock performance.

Source: The Motley Fool
This biotech innovator in rare disease therapies reported significant insider selling amid a year of robust stock performance.